Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event
Authors:
- French Study Group for Large Vessel Vasculitis (GEFA)F(French Study Group for Large Vessel Vasculitis (GEFA)
- Olivier EspitiaOEOlivier Espitia
Open Access
- 7 January 2021
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 23 (1) , 1-7
Abstract
Background: Giant cell arteritis (GCA) is frequently associated with aortic involvement that is likely to cause life-threatening structural complications (aneurysm, dissection). Few studies have investigated the occurrence of these complications, and no predictive factor has been identified so far. The aim of this study was to investigate factors associated with the risk of aortic complications in a cohort of GCA aortitis. Methods: Data of all patients managed with aortitis (CT or 18 FDG PET) at the diagnosis of GCA in five hospitals from May 1998 and April 2019 were retrospectively collected. Clinical features were compared according to the presence of aortitis symptoms. The predictive factors of occurrence or aggravation of aortic structural abnormalities were investigated. Results: One hundred and seventy-one patients with GCA aortitis were included; 55 patients (32%) had symptoms of aortitis (dorsal/lumbar/abdominal pain, aortic insufficiency) at diagnosis. The median follow-up was 38 months. Aortic complications occurred after a median time of 32 months. There were 19 new aortic aneurysms or complications of aneurysm and 5 dissections. Survival without aortic complication was significantly different between the symptomatic and non-symptomatic groups (Log rank, p = 0.0003). In multivariate analysis the presence of aortitis symptoms at diagnosis (HR 6.64 [1.95, 22.6] p = 0.002) and GCA relapse (HR 3.62 [1.2, 10.9] p = 0.02) were factors associated with the occurrence of aortic complications. Conclusion: In this study, the presence of aortitis symptoms at the diagnosis of GCA aortitis and GCA relapse were independent predictive factors of occurrence of aortic complications during follow-up.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Different patterns and specific outcomes of large-vessel involvements in giant cell arteritisJournal of Autoimmunity, 2019
- Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell ArteritisThe Journal of Rheumatology, 2019
- Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patientsAutoimmunity Reviews, 2018
- Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)La Revue de Médecine Interne, 2016
- Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort StudyThe Journal of Rheumatology, 2015
- Relapses in Patients With Giant Cell ArteritisMedicine, 2014
- Relapses and Recurrences in Giant Cell ArteritisMedicine, 2011
- Aortic Aneurysm and Dissection in Patients With Biopsy-Proven Giant Cell Arteritis From Northwestern SpainMedicine, 2004
- Incidence and predictors of large‐artery complication (aortic aneurysm, aortic dissection, and/or large‐artery stenosis) in patients with giant cell arteritis: A population‐based study over 50 yearsArthritis & Rheumatism, 2003
- Thoracic aortic aneurysm and rupture in giant cell arteritis. a descriptive study of 41 casesArthritis & Rheumatism, 1994